Natera (NASDAQ:NTRA) Price Target Raised to $210.00 at Piper Sandler
Natera (NASDAQ:NTRA – Get Free Report) had its price target raised by analysts at Piper Sandler from $205.00 to $210.00 in a report issued on Thursday,Benzinga reports. The firm presently has an “overweight” rating on the medical research company’s stock. Piper Sandler’s price target suggests a potential upside of 37.62% from the company’s previous close. […]
Natera (NASDAQ:NTRA – Get Free Report) had its price target raised by analysts at Piper Sandler from $205.00 to $210.00 in a report issued on Thursday,Benzinga reports. The firm presently has an “overweight” rating on the medical research company’s stock. Piper Sandler’s price target suggests a potential upside of 37.62% from the company’s previous close. […]
